Estimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA)

No abstract is available for this paper.

• Publication year

  2017

• Venue

  JAMA Oncology

• Publication date

  2017-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/jamaoncol.2016.3834PMID 27892978PMCID PMC5824323
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Effect of Gene Alterations and Tyrosine Kinase Inhibition on Survival and Cause of Death in Patients With Adenocarcinoma of the Lung and Brain Metastases.

  2016cited by this paper
• Extended Survival and Prognostic Factors for Patients With ALK-Rearranged Non-Small-Cell Lung Cancer and Brain Metastasis.

  2016cited by this paper
• Cancer statistics, 2016

  2016cited by this paper
• Pembrolizumab for the treatment of non-small-cell lung cancer.

  2015cited by this paper
• Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer.

  2015cited by this paper
• Global cancer statistics, 2012

  2015cited by this paper
• Stereotactic Radiosurgery With or Without Whole-Brain Radiotherapy for Brain Metastases: Secondary Analysis of the JROSG 99-1 Randomized Clinical Trial.

  2015cited by this paper
• Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study.

  2014cited by this paper
• Secondary analysis of RTOG 9508, a phase 3 randomized trial of whole-brain radiation therapy versus WBRT plus stereotactic radiosurgery in patients with 1-3 brain metastases; poststratified by the graded prognostic assessment (GPA).

  2013cited by this paper
• Crizotinib versus chemotherapy in advanced ALK-positive lung cancer.

  2013cited by this paper
• Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases.

  2012cited by this paper
• Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial.

  2012cited by this paper
• Global cancer statistics

  2011cited by this paper
• Intracranial Metastases: Current Management Strategies

  2008cited by this paper
• Management of Intracranial Metastases: History

  2008cited by this paper
• Brain metastases: epidemiology and pathophysiology

  2005cited by this paper
• Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials.

  1997cited by this paper
• Cancer statistics

  1989cited by this paper

• Palliative Care and Quality Outcomes in Patients With Brain Metastases and Poor Prognosis: A Multi-Institutional Analysis.

  2026cites this paper
• Research Advances in Radiotherapy Combined with Immunotherapy for Driver Gene-Negative NSCLC with Brain Metastases

  2026cites this paper
• Domvanalimab combined with zimberelimab as first-line treatment in patients with PD-L1–high, advanced non-small cell lung cancer: Results from the randomized phase 2 ARC-10 study, Part 1

  2026cites this paper
• Evaluation of the updated 2022 lung-GPA in NSCLC adenocarcinoma patients with brain metastases: analysis of prognostic factors in a German clinical cohort.

  2026cites this paper
• Irradiated tumor volume as a predictor of local recurrence and radionecrosis in lung cancer with brain metastases treated with stereotactic radiosurgery

  2026cites this paper
• Decreased overall survival in patients with brain metastases from non-small cell lung cancer with radiotherapy dose on the neurogenic niches

  2026cites this paper
• Commentary: Immuno-inflammatory signature for predicting therapeutic response and survival after stereotactic radiosurgery in NSCLC patients with brain metastases: a retrospective cohort study.

  2026cites this paper
• Brain metastases from non-small cell lung cancer: molecular subtypes and emerging CNS-directed precision therapies

  2026cites this paper
• Therapeutic advances with KRASG12C inhibitors and combination strategies in non-small cell lung cancer brain metastases.

  2026cites this paper
• Management von Tumormetastasen: Behandlung von Hirnmetastasen - Moderne Therapie zwischen kognitivem Erhalt und lokaler Kontrolle

  2025cites this paper
• Local Control After Single-Isocenter Dynamic Conformal Arc SRS for Brain Metastases

  2025cites this paper
• Primary and secondary metastatic dissemination: multiple routes to cancer-related death

  2025cites this paper
• Thérapies moléculaires ciblées en cancérologie pulmonaire

  2025cites this paper
• Survival predictive nomograms for non-surgical lung squamous-cell carcinoma patients with brain metastases: a SEER-based retrospective cohort study with external validation

  2025cites this paper
• Neurological Manifestations of Patients With CNS Metastases: Experience From a Single Center in an Upper-Middle-Income Country

  2025cites this paper
• Sacituzumab Tirumotecan in EGFR-TKI-Resistant, EGFR-Mutated Advanced NSCLC.

  2025cites this paper
• Treatment of oligometastatic non-small cell lung cancer with radiotherapy – single-centre experience

  2025cites this paper
• A retrospective study of radiotherapy combined with immunotherapy for patients with baseline brain metastases from non-small cell lung cancer

  2025cites this paper
• A stage IV lung squamous cell cancer patient with brain metastases, high PD-L1 & TMB, achieves pCR and long-term survival after immune-chemotherapy and radical surgery: a case report and literature review

  2025cites this paper
• Independent Prognostic Factors of Survival in Elderly Patients Undergoing Surgery for Non-small Cell Lung Cancer Brain Metastases: Assessing Surgical Eligibility.

  2025cites this paper
• Predicting the progressive-free survival of ALK-positive lung cancer: machine learning algorithm based on habitat imaging

  2025cites this paper
• Prevalence and Determinants of the Pool Sign in Lung Cancer Patients with Brain Metastasis.

  2025cites this paper
• Effect of combining targeted therapies or chemotherapy with stereotactic radiosurgery (SRS) on the prognosis of patients with brain metastases from non-small cell lung cancer (NSCLC)

  2025cites this paper
• Survival outcomes of upfront versus delayed craniocerebral radiotherapy in EGFR-mutant NSCLC patients treated with third-generation EGFR-TKIs

  2025cites this paper
• Postoperative absence of residual intracranial tumor volume is associated with improved survival and intracranial disease control in non-small cell lung cancer brain metastases

  2025cites this paper
• Breast Cancer Brain Metastasis: Bridging Biological Mechanisms to Therapeutic Innovations

  2025cites this paper
• Complete blood count parameters as potential predictive factors of brain metastases in lung cancer

  2025cites this paper
• Cerebrospinal fluid circulating tumor DNA profiling for risk stratification and matched treatment of central nervous system metastases

  2025cites this paper
• Brain metastases in non-small cell lung cancer: Prevalence, high-risk factors, and overall survival prognosis

  2025cites this paper
• Comparative safety and survival outcomes of immune checkpoint inhibitors in brain metastases from lung cancer: a propensity-matched cohort study

  2025cites this paper
• Immune Checkpoint Inhibitors +/− Chemotherapy for Patients With NSCLC and Brain Metastases: A Systematic Review and Network Meta‐Analysis

  2025cites this paper
• Prognostic Factors in Thyroid Cancer Patients With Brain Metastases: A Systematic Review and Meta-Analysis

  2025cites this paper
• Efficacy and safety of combining bevacizumab and fractionated stereotactic radiotherapy for extensive brain metastases in patients with non‐small cell lung cancer: a prospective phase II study (GASTO‐1053)

  2025cites this paper
• Key genes associated with brain metastasis in non-small cell lung cancer: novel insights from bioinformatics analysis

  2025cites this paper
• The stereotactic radiosurgery-brain prognostic index (SRS-BPI): A novel prognostic index for SRS-eligible lung cancer patients with brain metastases

  2025cites this paper
• Investigational new drugs to treat brain metastasis from non-small cell lung cancer

  2025cites this paper
• A novel optimized orthotopic mouse model for brain metastasis with sustained cerebral blood circulation and capability of multiple delivery

  2025cites this paper
• Prognostication of Brain-Metastasized Patients Receiving Subsequent Systemic Therapy: A Single-Center Long-Term Follow-Up

  2025cites this paper
• Effect of cumulative dexamethasone dose on the outcome of patients with radiosurgically treated brain metastases in the era of modern oncological therapy.

  2025cites this paper
• Factors Affecting the Prevalence and Survival of Patients with Primary and Metastatic Brain Tumors

  2025cites this paper
• Outcomes in Patients with Non-Small-Cell Lung Cancer with Brain Metastases: A Real-World Data Study from a Resource-Limited Country

  2025influential citation
• Abscess formation within brain metastasis

  2025cites this paper
• Unsupervised Clustering Successfully Predicts Prognosis in NSCLC Brain Metastasis Cohorts

  2025cites this paper
• Complete resection of brain metastases – when does it matter?

  2025cites this paper
• Coplanar DCA-based hypofractionated stereotactic radiotherapy for very small brain metastasis from non-small cell lung cancer: treatment planning comparison with coplanar VMAT and preliminary clinical outcome

  2025cites this paper
• Development and validation of a dynamic nomogram for predicting brain metastasis in stage III NSCLC patients undergoing definitive chemoradiotherapy

  2025cites this paper
• Pilot Study of Metabolomic Biomarkers Associated with Outcomes in Patients with Lung Cancer Undergoing Radiation Therapy

  2025cites this paper
• Integrated nomogram for predicting intracranial progression-free survival with EGFR-TKI combined with cranial radiotherapy: a multicenter study.

  2025cites this paper
• Analysis of prognostic factors influencing brain metastasis in EGFR-mutant lung adenocarcinoma and comparison of prognostic assessment models

  2025cites this paper
• Pomegranate extract-loaded PEG-PLGA nanoparticles exhibit potent antimetastatic activity against oral squamous cell carcinoma: an in vitro study

  2025influential citation
• In the context of the era of targeted therapy: evaluation of the survival benefits of different local treatment modalities for patients with 1–3 brain metastases from non-small cell lung cancer

  2025cites this paper
• Prognostic scores for patients with multiple brain metastases treated with repeated stereotactic radiosurgery - a secondary analysis of the CYBER-SPACE randomized phase 2 trial.

  2025cites this paper
• Surgical outcomes and prognostic factors in 228 patients with brain metastases: a focus on en bloc resection and multimodal therapy

  2025influential citation
• Dose-Incorporated Deep Ensemble Learning for Improving Brain Metastasis SRS Outcome Prediction.

  2024cites this paper
• Adrenergic microenvironment driven by cancer‐associated Schwann cells contributes to chemoresistance in patients with lung cancer

  2024cites this paper
• Prognosis versus Actual Outcomes in Stereotactic Radiosurgery of Brain Metastases: Reliability of Common Prognostic Parameters and Indices

  2024cites this paper
• Comprehensive genomic and clinical analyses identify APOBEC mutational signatures as a brain metastasis risk factor in lung adenocarcinoma patients

  2024influential citation
• Identifying Pathological Subtypes of Brain Metastasis from Lung Cancer Using MRI-Based Deep Learning Approach: A Multicenter Study

  2024cites this paper
• Treatment outcomes and prognostic factors in patients with driver mutant non-small cell lung cancer and de novo brain metastases

  2024cites this paper
• Current pharmacologic treatment of brain metastasis in non-small cell lung cancer

  2024cites this paper
• Validation of the Lung-Mol Graded Prognostic Assessment (GPA) System for the Prognosis of Patients Receiving Radiotherapy for Brain Metastasis From Non-small Cell Lung Cancer

  2024influential citation
• Immunotherapy combined with cranial radiotherapy for driver-negative non-small-cell lung cancer brain metastases: a retrospective study.

  2024cites this paper
• Predicting Survival with Brain Metastases in the Stereotactic Radiosurgery Era: are Existing Prognostic Scores Still Relevant? Or Can we do Better?

  2024cites this paper
• A brain metastasis liquid biopsy: Where are we now?

  2024cites this paper
• Risk factors for brain metastases in locally advanced non-small cell lung cancer patients treated with radical radiotherapy

  2024cites this paper
• Focused ultrasound assisted delivery of immunomodulating agents in brain cancer: A review.

  2024cites this paper
• MRI radiomics for predicting intracranial progression in non-small-cell lung cancer patients with brain metastases treated with epidermal growth factor receptor tyrosine kinase inhibitors.

  2024cites this paper
• Converging survival trends in non-small cell lung cancer patients with and without brain metastasis receiving state-of-the-art treatment

  2024cites this paper
• Beta-Adrenergic Blockade in Advanced Non-Small Cell Lung Cancer Patients Receiving Immunotherapy: A Multicentric Study

  2024cites this paper
• Random forests to predict survival of octogenarians with brain metastases from nonsmall‐cell lung cancer

  2024cites this paper
• Prognostic significance of integrating total metabolic tumor volume and EGFR mutation status in patients with lung adenocarcinoma

  2024cites this paper
• Enhancing outcomes: neurosurgical resection in brain metastasis patients with poor Karnofsky performance score - a comprehensive survival analysis

  2024cites this paper
• Exploring the Molecular Tumor Microenvironment and Translational Biomarkers in Brain Metastases of Non-Small-Cell Lung Cancer

  2024cites this paper
• KIF20B Correlates with LUAD Progression and Is an Independent Risk Factor.

  2024cites this paper
• Radiotherapy in Preclinical Models of Brain Metastases: A Review and Recommendations for Future Studies

  2024cites this paper
• The Efficacy of Anlotinib Plus Whole Brain Radiotherapy in Advanced Non‐Small Cell Lung Cancer With Multiple Brain Metastases: A Retrospective Study

  2024cites this paper
• Targeting CNS Metastases in Non-Small Cell Lung Cancer With Evolving Approaches Using Molecular Markers: A Review.

  2024cites this paper
• Optimal intervention timing for craniocerebral radiotherapy in EGFR mutant lung adenocarcinoma patients with brain metastases

  2024cites this paper
• A phase II study of anlotinib plus whole brain radiation therapy for patients with NSCLC with multiple brain metastases

  2024influential citation
• Targeting EGFR Exon 20 Insertion Mutations in Non-small-Cell Lung Cancer: Changes in Treatment Strategies are Coming

  2024cites this paper
• Validation of the graded prognostic assessment and recursive partitioning analysis as prognostic tools using a modern cohort of patients with brain metastases.

  2024cites this paper
• Predicting local control of brain metastases after stereotactic radiotherapy with clinical, radiomics and deep learning features

  2024cites this paper
• Survival prognostic factors in nonsmall cell lung cancer patients with simultaneous brain metastases and poor performance status at initial presentation

  2024cites this paper
• GABA(A) Receptor Activation Drives GABARAP–Nix Mediated Autophagy to Radiation-Sensitize Primary and Brain-Metastatic Lung Adenocarcinoma Tumors

  2024cites this paper
• MicroRNAs in Lung Cancer Brain Metastasis

  2024influential citation
• Outcomes with non-small cell lung cancer and brain-only metastasis

  2024cites this paper
• Pre-stereotactic radiosurgery neutrophil-to-lymphocyte ratio predicts post-stereotactic radiosurgery survival of patients with brain metastases concurrently treated with immune checkpoint inhibitors.

  2024cites this paper
• Development of brain metastases in non-small-cell lung cancer: high-risk features

  2024cites this paper
• PD-1 blockade does not improve efficacy of EpCAM-directed CAR T-cell in lung cancer brain metastasis

  2024cites this paper
• Validity test of small cell lung cancer (SCLC) graded prognostic assessment and proposal of a new index for patients with brain metastases from SCLC

  2024cites this paper
• Characterization of the tumor microenvironment in breast cancer brain metastasis

  2024cites this paper
• Tyrosine Kinase Inhibitors With and Without Up-Front Stereotactic Radiosurgery for Brain Metastases From EGFR and ALK Oncogene–Driven Non–Small Cell Lung Cancer (TURBO-NSCLC)

  2024cites this paper
• Assessing survival in non-small cell lung cancer brain metastases after stereotactic radiosurgery: before and after the start of the targetable mutation era

  2024cites this paper
• [First-line immunotherapy in non-small cell lung cancer diagnosed with brain metastases].

  2024cites this paper
• Prediction of prognosis in lung cancer using machine learning with inter-institutional generalizability: A multicenter cohort study (WJOG15121L: REAL-WIND).

  2024cites this paper
• The Effect of Intracranial Control After Intracranial Local Therapy on the Prognosis of Patients with Brain Metastasis of Lung Adenocarcinoma

  2024cites this paper
• Dissecting the MUC5AC/ANXA2 signaling axis: implications for brain metastasis in lung adenocarcinoma

  2024cites this paper
• Ivonescimab Plus Chemotherapy in Non-Small Cell Lung Cancer With EGFR Variant: A Randomized Clinical Trial.

  2024cites this paper
• Site-Specific Response and Resistance Patterns in Patients with Advanced Non-Small-Cell Lung Cancer Treated with First-Line Systemic Therapy

  2024cites this paper
• Prognostic Factors and Impact of Therapeutic Intervention in Patients With Brain Metastases at the Initial Presentation

  2024cites this paper